High BRCA1 expression in drug‐resistant ovarian cancer cells has been shown to enhance cellular DNA repair capability, making cells less susceptible to chemotherapeutic drugs and leading to drug resistance (Zhou, Smith, & Liu, 2003). The gene discussed is BRCA1; the disease is ovarian carcinoma.